Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer

Jing Wu1, Zuojun Shen1,2

  • 1Department of Clinical Laboratory, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui, P.R. China.

Cancer Medicine
|August 12, 2020
PubMed

Insights

Exosomes carrying microRNAs (miRNAs) and other noncoding RNAs (ncRNAs) show potential as lung cancer biomarkers. Further research is needed to confirm their diagnostic and prognostic value in patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Exosomes facilitate intercellular communication by transferring molecules like microRNA (miRNA) and long noncoding RNA (lncRNA).
  • These exosomal RNAs are increasingly implicated in the development and progression of lung cancer.
  • The presence of RNA-containing exosomes in body fluids has spurred interest in their clinical applications.

Purpose of the Study:

  • To review current evidence on exosomal miRNAs and other ncRNAs as diagnostic and prognostic markers for lung cancer.
  • To highlight the role of exosomal RNAs in lung cancer pathogenesis and intercellular communication.

Main Methods:

  • Review of human studies focusing on exosomal miRNAs and ncRNAs in lung cancer.
  • Analysis of existing data regarding the diagnostic and prognostic potential of these biomarkers.

Main Results:

  • Exosomal miRNAs and ncRNAs are present in various body fluids.
  • Preliminary evidence suggests exosomal miRNAs can serve as early diagnostic and prognostic indicators for lung cancer.
  • The precise roles and clinical utility require further investigation.

Conclusions:

  • Exosomal RNAs represent a promising, minimally invasive source for lung cancer biomarkers.
  • Additional research is essential to validate exosomal miRNAs and ncRNAs for clinical use in lung cancer diagnosis and prognosis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K